OCT4 is a POU-domain transcription factor. It is present on chromosome 6p21.3. Oct4 maintains pluropotentiality. It is detectable in embryonic stem and germ cells but downregulated in all differentiated somatic cell types5. It binds transcription sites through octamer motifs, including that for fibroblast growth factor 4 and platelet-derived growth factor a receptor3. Knockout of the gene is lethal in mice2. Staining is nuclear.
Undifferentiated pluripotent cells
Germ cells of the ovary and testis, but not resting oocytes. It is not expressed by brain, heart, liver, spleen, skeletal muscle, lung, kidney or pancreas4.
Germ cell tumours:
Testicular tumours |
OCT4 |
|||
Carcinoma in situ |
positive2 |
|||
Mixed germ cell tumour (64 cases1), containing various combinations of components |
seminoma |
51/51 (all showed strong (3+) staining)1, 49/492 |
||
embryonal carcinoma |
54/54 (all but one case showed strong (3+) staining)1, positive2 |
|||
yolk sac tumour |
0/381, negative2 |
|||
mature teratoma |
0/311, negative2 |
|||
immature teratoma |
0/201, negative2 |
|||
choriocarcinoma |
0/151, negative2 |
|||
Spermatocytic seminoma |
0/51, negative2 |
|||
Leydig cell tumour |
0/81 |
|||
Sertoli cell tumour |
0/61 |
|||
Unclassified sex cord stromal tumour |
0/41 |
|||
Adenomatoid tumour |
0/21 |
|||
Testicular tumour of adrenogenital syndrome |
0/11 |
|||
Granulosa cell tumour |
0/11 |
|||
Ovarian tumours |
||||
Germ cell tumour |
Ovarian dysgerminoma |
2/22, 35/35 (strong diffuse positivity: 32 primary and 3 metastatic tumours: syncytiotrophoblastic cells were negative)4 |
||
Gonadoblastoma |
1/12, 2/2 (positive in the germ cell component: the sex cord components were negative)4 |
|||
Mature teratoma |
0/144 |
|||
Yolk sac tumour |
0/44 |
|||
Embryonal carcinoma |
no data4 |
|||
Leydig cell tumour |
0/14 |
|||
Sertoli cell tumour |
0/14 |
|||
Sertoli-Leydig cell tumour |
0/134 |
|||
Granulosa cell tumour |
Adult type |
0/134 |
||
Juvenile type |
0/94 |
|||
Brenner tumour |
0/34 |
|||
Carcinoid tumour |
0/44 |
|||
Struma ovarii |
0/24 |
|||
Fibroma |
0/54 |
|||
Thecoma |
0/14 |
|||
Clear cell adenocarcinoma |
4/14 (four cases showed staining of <10% of cells)4 |
|||
Serous adenocarcinoma |
0/54 |
|||
Endometrioid adenocarcinoma |
0/44 |
|||
Small cell carcinoma, hypercalcaemic type |
0/64 |
|||
Stromal sarcoma |
0/14 |
|||
Lymphoma |
Diffuse large B-cell type |
0/24 |
||
Burkitt's |
0/34 |
|||
Small cleaved B-cell type |
0/14 |
|||
Metastatic malignant melanoma |
0/14 |
|||
Metastatic carcinoid |
0/24 |
|||
Metastatic small cell carcinoma |
0/14 |
|||
Metastatic lobular carcinoma of the breast |
0/14 |
|||
Non-gonadal tumours |
||||
CNS |
germinoma |
25/25 (staining intense in 22 cases, absent from the teratomatous component of one case of mixed germ cell tumour. PLAP was positive in 23 of 25 cases.)5 |
||
glioblastoma multiforme |
0/105 |
|||
lymphoma |
0/45 |
|||
pineoblastoma |
0/35 |
|||
metastatic malignant melanoma |
0/45 |
|||
capillary haemangioma |
0/105 |
|||
pituitary adenoma |
0/55 |
|||
meningioma |
0/45 |
|||
Schwannoma |
0/45 |
|||
metastatic carcinoma |
0/5 (2 lung, 2 colon, 1 breast)5 |
|||
non-testicular tumour microarray of 3439 tumours2, all non-gonadal tumours negative, except: |
Pulmonary squamous cell carcinoma |
1/502 |
||
Pulmonary large cell carcinoma |
1/472 |
|||
Renal clear cell carcinoma |
1/502 |
|||
diagnosis of seminoma, CNS germinoma, ovarian dysgerminoma4 and embryonal carcinoma.
the ovarian tumours that form the differential for dysgerminoma are negative. Clear cell carcinoma may be positive, but occurs in older women.
possibly in the differentiation of ovarian clear cell carcinoma from yolk sac tumour, endometrioid of serous carcinoma4.
identification of a germ cell element, differentiating gonadoblastoma from pure sex cord stromal tumours.
References
2Looijenga, L. H., H. Stoop, et al. (2003). "POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors." Cancer Res 63(9): 2244-50. FULL TEXT AVAILABLE ON LINE.
This page last revised 18.3.2005.
©SMUHT/PW Bishop